Next Article in Journal
Independent Living for Older Adults with Cognitive Impairment: A Narrative Review of Stakeholder Perceptions and Experiences with Assistive and Socially Assistive Robots
Next Article in Special Issue
Polypharmacy and the Use of Potentially Inappropriate Medications in Elderly People in Nursing Homes: A Cross-Sectional Study
Previous Article in Journal
Linguistic Validation and Cultural Adaptation of the Albanian Version of the Older People’s Quality of Life Questionnaire (AL-OPQOL-35)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Healthcare Redesign of Medication Management for Parkinson’s Inpatients

by
Susan Williams
1,
Marissa Anne Iannuzzi
1 and
Sarah J. Prior
2,*
1
Royal North Shore Hospital, New South Wales Health, Sydney, NSW 2065, Australia
2
Tasmanian School of Medicine, University of Tasmania, Burnie, TAS 7320, Australia
*
Author to whom correspondence should be addressed.
J. Ageing Longev. 2025, 5(3), 33; https://doi.org/10.3390/jal5030033
Submission received: 26 June 2025 / Revised: 8 August 2025 / Accepted: 21 August 2025 / Published: 15 September 2025
(This article belongs to the Special Issue Medication Management and Medication Safety in Older Adults)

Abstract

Parkinson’s disease is a progressive neurological disorder reliant on medication regime adherence to alleviate symptomology. When hospitalised, people with Parkinson’s disease have specific medication management needs which are consistently unmet. This study aims to develop, implement and evaluate solutions for improving the medication management of inpatients with Parkinson’s disease. A healthcare redesign approach was utilised, focusing on the final three phases: solutions design, implementation and evaluation. Five solutions were derived: formalise routine patient identification, provide improved staff education, develop and install automated prescriber alerts, review and amend ward PD medication stock, and develop systematic prompts for PD medications. The findings suggest that our solutions sustainably improved systems and processes that contribute to quality and safe medication management for Parkinson’s patients. Correct identification of Parkinson’s patients within an acute care hospital leads to correct prescription of medications, timeliness of medication administration and timely pharmacy review. The length of stay was not positively impacted.
Keywords: Parkinson’s disease; quality and safety; patient experience; patient outcomes; medication; healthcare redesign Parkinson’s disease; quality and safety; patient experience; patient outcomes; medication; healthcare redesign

Share and Cite

MDPI and ACS Style

Williams, S.; Iannuzzi, M.A.; Prior, S.J. Healthcare Redesign of Medication Management for Parkinson’s Inpatients. J. Ageing Longev. 2025, 5, 33. https://doi.org/10.3390/jal5030033

AMA Style

Williams S, Iannuzzi MA, Prior SJ. Healthcare Redesign of Medication Management for Parkinson’s Inpatients. Journal of Ageing and Longevity. 2025; 5(3):33. https://doi.org/10.3390/jal5030033

Chicago/Turabian Style

Williams, Susan, Marissa Anne Iannuzzi, and Sarah J. Prior. 2025. "Healthcare Redesign of Medication Management for Parkinson’s Inpatients" Journal of Ageing and Longevity 5, no. 3: 33. https://doi.org/10.3390/jal5030033

APA Style

Williams, S., Iannuzzi, M. A., & Prior, S. J. (2025). Healthcare Redesign of Medication Management for Parkinson’s Inpatients. Journal of Ageing and Longevity, 5(3), 33. https://doi.org/10.3390/jal5030033

Article Metrics

Back to TopTop